In Depth Review,C-peptide is an enzymatic cleavage product that arises from proinsulin

The intricate process of insulin production within the pancreas involves several key molecular players, with proinsulin serving as the direct precursor. A crucial component of this precursor molecule is the C-peptide, which plays a vital role in the proper formation and eventual release of insulin. Understanding the relationship between proinsulin and C-peptide is essential for comprehending beta-cell function and diagnosing various metabolic conditions, particularly diabetes.

Proinsulin, a single polypeptide chain, is synthesized in the endoplasmic reticulum within pancreatic beta cells. It is essentially an immature form of insulin that requires further processing before it becomes biologically active. This processing involves the cleavage of a connecting segment, which is precisely where C-peptide comes into play. The C-peptide (connecting peptide) connects the alpha and beta chains of proinsulin, acting as a linker that facilitates the correct folding and assembly of these chains into the mature insulin molecule. This structural role is critical; without the C-peptide, the A and B chains of insulin would not be properly aligned for efficient folding.

Once proinsulin has folded correctly due to the presence of the C-peptide, it moves to the Golgi apparatus and then to secretory granules. Within these granules, enzymatic cleavage occurs, removing the C-peptide. This process yields one molecule of mature insulin and one molecule of free C-peptide. It is important to note that the C-peptide itself has no significant biologic activity on its own concerning glucose regulation, unlike insulin. However, its presence in the blood is a direct indicator of endogenous insulin production.

The fact that insulin and C-peptide are secreted in equimolar concentrations from the pancreas makes the C-peptide test a valuable diagnostic tool. When insulin is administered exogenously (e.g., in diabetes treatment), the body's own insulin production, and thus its C-peptide levels, remain largely unaffected. This allows healthcare professionals to distinguish between insulin produced by the body and insulin introduced from external sources. A C-peptide test measures the amount of C-peptide in the blood or urine, providing a reliable marker of how much insulin the pancreas is producing.

Furthermore, research has indicated that proinsulin itself can have a direct biologic effect, though it is significantly less potent than insulin. Interestingly, proinsulin can exhibit some cross-reactivity with both C-peptide and insulin in certain assays, with reported proinsulin cross-reactivity being as low as 0.1% with both C-peptide and insulin. This highlights the importance of using specific assays for accurate measurement.

The C-peptide is a chain of amino acids, specifically a 31-amino acid polypeptide. Its removal from proinsulin is a precise enzymatic event, typically mediated by proteases such as PC2 and PC1/3. The excised C-peptide is then stored in the secretory granule alongside mature insulin before being released into the bloodstream. This release into the blood stream in equal amounts to insulin is a key principle behind its diagnostic utility.

In certain autoimmune conditions, such as type 1 diabetes, the immune system can mistakenly target components of the insulin-producing machinery. Studies have shown that C-peptide, derived from proinsulin, can be recognized by CD4+ T cells in individuals with recent-onset type 1 diabetes, suggesting that C-peptide can act as an autoantigen in these cases.

The C-peptide's journey from being an integral part of proinsulin to its release as a byproduct of insulin synthesis underscores its significance. It not only facilitates the proper folding of insulin but also serves as a reliable indicator of pancreatic beta-cell secretory function. This is particularly useful in managing diabetes, where monitoring endogenous insulin production can guide treatment strategies and assess the remaining capacity of the pancreas. The free connecting segment of proinsulin can be detected and is named C-peptide. The C peptide is between the A and B chains of proinsulin.